| Accession |
PRJCA011217 |
| Title |
Short-term efficacy of decitabine-dominant therapy in JMML: a retrospective study from a single center in China |
| Relevance |
Medical |
| Data types |
Epigenomics
Variation
|
| Organisms |
Homo sapiens
|
| Description |
Decitabine-dominant therapy was favorable in reducing tumor burden and improving the clinical status of JMML patients. |
| Sample scope |
Multiisolate |
| Release date |
2024-03-27 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| National Natural Science Foundation of China (NSFC)
|
|
81900135
|
|
| Ministry of Science and Technology of the People's Republic of China (MOST)
|
|
2019YFA0110803
|
|
| Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
|
|
2018RC310019
|
|
| Medical science and Health Technology Innovation Project of Chinese Academy of Medical Sciences
|
|
2021-I2M-1-003
|
|
|
|
| Submitter |
Xiaofan
Zhu (xfzhu@ihcams.ac.cn)
|
| Organization |
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College |
| Submission date |
2022-08-15 |
